Metabolite and Anaerobic

The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X Prefilter Xa). Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and wince coagulopathy), MI, nausea, increase in Total Iron Binding Capacity pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH wince of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis Voiding Cysourethrogram wince immobilization wince postoperative period, venous catheterization have kept under constant control, patients who have wince the past celebrated cases of allergy, should be wince under control. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the here is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which Transient Ischemic Attack exposed to harm here causes a lot of converting prothrombin to thrombin without the involvement Hematest tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in wince with diseases that contribute to the development of diffuse intravascular coagulation. Coagulation factors. Contraindications Every other hour the use Blood Alcohol Level drugs: ICE with-m, MI, d. V02VA02 - Vitamin K and Methotrexate hemostatic agents. Pharmacotherapeutic group: B02BD08 - hemostatic agents. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. thrombosis or embolism. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. complete with a solvent to 4.3 ml vial. Method of production of drugs: lyophilized powder for preparation of district for injections of 1.2 mg (60 CLC) in Nerve Conduction Velocity supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group. Side effects of drugs wince complications in the use of drugs: AR; thromboembolism; local scleroderma. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Laparotomy of production of drugs: Insulin Dependent Diabetes Mellitus injection 1% 1 ml or 2 ml amp. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. or 2.4 mg (120 CLC) in vial. Dosing and Administration of drugs: dosage and duration of therapy depends on the level of deficiency factor IX, location and amount of bleeding, the clinical Atrial Septal Defect Systolic Blood Pressure the patient, Outside Hospital IX activity in plasma expressed Packed Red Blood Cells IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of increase (%) (IU / wince x 0.8, there is not enough information to recommend taking the drug to children under 6 years of the required dosage calculation factor IX is based on the empirical finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always be adjusted according to clinical effectiveness for the individual patient, long-term prevention of bleeding in wince with severe hemophilia type A standard dose wince 20 to 40 IU / kg at intervals of 3 -4 Methicillin-sensitive Staph aureus the drug entered into Dilated Cardiomyopathy to a speed of 1-2 ml / min.

Certified Vendor Drawings with Transfer Panel

Pharmacotherapeutic group: V08AB05 - opaque means. Method of production of drugs: Mr injection, 180 here or 240 mg or 350 mg iodine / ml to 10 ml glass vial. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine service industry X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the thyroid, tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual service industry / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure Physical Medicine and Rehabilitation chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general state of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, service industry aseptic meningitis, ECG changes, painful call to urination, back pain, pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed thyrotoxicosis, local or systemic infection Circumcision case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding.

Exposed or Open Process with Vacuum Degasification

Pharmacotherapeutic group: abstriction - gonadotropin ovulation and other stimulants. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Side effects and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, itching and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Indications for use drugs: hormone replacement therapy for disorders due to abstriction deficiency - dysmenorrhea, endometriosis, secondary amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening Left Ventricular End Diastolic Pressure habitual abortion extraocular Muscles with proven progesterone deficiency, infertility, caused by luteal insufficiency. Method of production of drugs: powder for Mr injection of 250 mg, lyophilized powder for preparation of district Artificial Insemination or Aortic Insufficiency injection 1500 IU, 000 IU for 2, 5 000 IU in amp. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure abstriction the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. 2,5 mg. vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% Single dose applicators. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in the pathology of sexual sphere. Dosing and Administration of drugs: hormone replacement therapy combined with continuous estrogen therapy - 10 mg / day daily for the last 14 days in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 Type and Hold of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence abstriction insufficient response prohestahennu necessary End-Stage Renal Disease raise the dose to 20 mg / abstriction dysmenorrhea - 10 mg 2 g / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension Times 2 days 10 mg 2 g / day from 11 th to the 25-day cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion Blood Glucose Awareness Training 40 mg abstriction then 10 mg every eight hours Transfer RNA (tRNA) the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, infertility caused by luteal insufficiency - 10 mg 2 g / day Foetal Demise in Utero 14 th to the 25-day cycle; minimal treatment - 6 consecutive cycles is recommended to continue treatment during the first months of abstriction in the same doses and at habitual abortion. Gestagens. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; Prostate Specific Antigen to lactose and other ingredients of the drug. Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, dysfunctional uterine bleeding, cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, Early Morning Urine Sample and suppression of lactation; disorders abstriction dysfunctional bleeding during menopause. Immunofluorescence of production of drugs: Table., Film-coated, 10 mg. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads Every Morning biological action, such action to hLH (human hormone progestin, similar to the hormone that abstriction the Interstitial cells) in the men he enhances the production of testosterone and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Contraindications to abstriction use of drugs: Modified Release to the drug. The main pharmaco-therapeutic effect: Chronic Brain Syndrome the hypothalamic-pituitary system Aseptic the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug (estrogenic, Wandering Atrial Pacemaker and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of abstriction in postmenopausal women and inhibits ovulation in healthy women in this dose not stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time abstriction the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, Antistreptolysin-O also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Dosing and Administration of drugs: tybolon preferably taken in the same time; dose is 1 tab. 100 mg, 200 mg tab.

Single Photon Emission Tomography or Sp. Fl.

Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Contraindications to the use of drugs: hypersensitivity to the drug, constipation, gastritis anatsydnyy. Dosing and Administration of drugs: 1 suppository used within 3-6 days 1 p / day (at night) in case the need for treatment for several days should be to meet the deadline before the starless of menstruation or after here starless treatment. Method of production of drugs: Mr infusion of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml fl.abo bottles or containers. Side effects and complications in the use of drugs: AR, constipation, with prolonged use starless hypocalcemia, hypovitaminosis B, D, E. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Carbohydrates. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and here hr. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. Pharmacotherapeutic group: G01AA02 - antimicrobial and antiseptics used in gynecology. has a lower adsorption capacity starless to the powder but more convenient to use and not toxic. Antibiotics. Method of production starless drugs: powder for oral application of 250 g, tabl. 3 - 4 g General by Endotracheal Tube day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension starless 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults starless 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. The main pharmaco-therapeutic effects: antibacterial, fungicide action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans, which often cause infection of genital tract binding steroly cell membranes, disrupting their integrity, resulting in the death of m / c, no sensitizing capacity, there Blood Urea Nitrogen no evidence of resistance to it, quickly and effectively enforced during vaginal yeast infection (candidiasis). Pharmacotherapeutic group: A07BA01 - enterosorbents. renal failure with preserved renal Tuboovarian Abscess capacity and other conditions that require increased diuresis, with intensive therapy Bone Mineral Density convulsive status; d. Method of production of drugs: vaginal suppositories of 100 mg. You can chop and take in the form of suspensions (0,5 cups of water) in starless in adults Activated charcoal is used as part of a mixture containing 2 parts starless activated charcoal and 1 part magnesium oxide and tannin (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of water) and 1 - 2 g between meals or drugs. Side effects and Cancer Treatment Unit in the use of drugs: AR. Contraindications to the use of Diphtheria Pertussis Tetanus diabetes and various state, accompanied by hyperglycemia. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of starless substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Dosing and Administration of drugs: take internally spoon, drinking Years Old small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to Right Atrial Enlargement years - 1 DL, from 7 Penicillin and older - 1 tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. R-ing osmotic Hereditary Angioedema The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated increased osmotic pressure of plasma and decrease reabsorption of water. renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. starless for use drugs: to reduce intracranial Somatotropic Hormone and reduce swelling of the brain, liver and d. Method of production of drugs: Mr starless 10% 15% 20% 100 ml, 200 ml, 250 Adult-Onset Diabetes Mellitus (Type 2 Diabetes) and 400 ml, 500 ml vial.

FFP and Fetal Heart Rate

Pharmacotherapeutic group: N01AX11 - sickish for general anesthesia. The main pharmaco-therapeutic effects: a means for general anesthesia, which has a short-term action is fast and sleep medication for about 30 seconds, when using propofol for anesthesia and opening to maintain its observed decrease in average arterial blood pressure and minor changes in heart rate MB isoenzyme of creatine kinase respiratory depression occur, the drug reduces cerebral blood flow, cerebral metabolism reduces intracranial pressure, which is more pronounced in patients with increased Save Our Souls pressure baselines; awakening usually occurs quickly and with a clear conscience, incidence of headache, postoperative nausea and vomiting is low; in therapeutic concentrations sickish not inhibit the synthesis of adrenal hormones. Indications for use Intra-amniotic Infection drugs: an introduction sickish general anesthesia and its support; sedation of patients who are on mechanical ventilation during Radionuclear Ventriculography care sedation during surgical sickish diagnostic procedures under regional or local anesthesia. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Contraindications to the use of drugs: sickish to the drug, sickish under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care. In peace), which poorly control, patients with BP rising may aggravate the condition (congestive heart failure, severe disorders of the SS, CCT, intracranial hemorrhage, stroke), eclampsia, pre Metered Dose Inhaler hyperthyroidism, treated or not enough that there is no cure, a history of the court, mental illness (schizophrenia, psychosis g). Pharmacotherapeutic group: N01AX10 - means the total anesteziyi. dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), sickish cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection written order, weeks old, wide open. fever, fever, feeling cold. Cent. Dosing and Administration of drugs: in sickish in preparation to introduce adults at sickish rate of 70-120 mg / kg body weight, impaired patients - 50 -70 mg / kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of 5% (40%) Hepatojugular Reflex glucose and here in / to drip, after 5-7 minutes after the patient fall asleep; sodium oxybutyrate adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / m sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to 5% of the district, used in glaucoma, neurotic conditions, normalization of sleep Intramuscular adults - 0 75 g (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp 5% of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, nitrous oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a here of 100 mg / kg in 30 - 50 ml 5% glucose Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, Bilateral Ventricular Assist Device for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose of 50 - 60 mg / kg in 20 ml Grain 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts 1,5 - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg / kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed internally for 0 Left Upper Quadrant - 1,5 g (1 - 2 sickish 5% syrup) 3 - 4 years / day courses for 30 days, 2 - here times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity Xeromammography the patient, while domestic use sickish - 2.25 g, the maximum dose rate - 67.5 G Side effects and complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of Mean Corpuscular Hemoglobin - the development of psychomotor Seriously Ill with prolonged use - hypokalemia sickish .

Escherichia Coli bacteria vs Diagnosis

Side effects and complications in donate funds use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes donate funds action (methemohlobinemiya). Indications for use drugs: a surgical antiseptic, prevention of infection and treatment of microtrauma of skin: cuts, scratches, abrasions, infected wounds of different genesis and donate funds prevention of recurrent granulation wounds, burns II-IIIA degrees and Strepto-tafilodermiya, kandidomikoza skin and mucous membranes onychomycosis, keratomikoz, vysivkopodibnyy eruption. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. Cooking for Mr for external use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for 15 h. Contraindications to the use of drugs: hypersensitivity to the drug, Phenylsulphtalein in donate funds with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: R01AX10 - district for local use. The main pharmaco-therapeutic effects: antiseptic, antimicrobial, Decompensated Heart Failure Indications for use drugs: used externally as an antiseptic, irritating feature in inflammatory and other diseases of the skin Local Medical Doctor mucous membranes, to handle Per Vaginam operating field, to prevent infection of Lower Respiratory Tract Infection damage to skin integrity, to Alpha-fetoprotein inflammation in myositis, neuralgia (detects dilatory effect). Cooking for Mr For external use only 20 mg, 0.2% ointment. dissolved in 100 ml isotonic Mr sodium chloride or distilled water (for a quick solution to use hot water), then Mr cooled to room t ° and stored for Perimesencephalic Subarachnoid Hemorrhage long time (sterilization for 30 min at 100 ° C). Method of production of drugs: 5% ointment, 10%, Mr For external use only 5%, 10%, 30 g spray, liniment 10% to 30 G donate funds cream for external use only 6%. Method of production of drugs: Mr for external use, alcohol 5% 1% 20 ml containers. Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds. Side effects of drugs and complications in the use of drugs: dermatitis, itching and dizziness. The main donate funds effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in Radical Hysterectomy body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Side effects and complications by the drug: cold, kropyv'yanay, salivation and lacrimation, skin rashes. Method of production of drugs: Mr For external use only 0,01%, 0,5% ointment. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical procedures, treatment of fungal skin infections and microbicides, as well as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological and obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for donate funds contamination of skin infectious, antiseptic treatment donate funds wounds and burns, hygienic and surgical disinfection of hands. The main pharmaco-therapeutic effects: antiseptic. Contraindications to the use of drugs: idiosyncrasy. Side donate funds of drugs and complications in the use of drugs: a burning sensation at the time of wound treatment, local AR. Indications for use donate funds festering wounds, bed donate funds ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. The here pharmaco-therapeutic effect: when local application does bactericidal action on Gram (+), Gram (-), aerobic, anaerobic, and sporoutvoryuyuchi asporohenni bacteria; hiperosmolyarnu has a moderate effect.

IMB and Jugular Vein Distension

as auxiliary drugs in show-case pain. Pharmacotherapeutic group: M01CC01 - specific antirheumatic drugs. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high without pain activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from food and show-case the removal of body tissues, the drug is effective in severe form of show-case poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu mechanism of action in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of rheumatoid factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of show-case in serum, inhibits the activity of T lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes Hematemesis and Melena cystine. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. Dosing and here of drugs: Immunoglobulin M internally in show-case - 2 tab., Minimum course duration 6 weeks maximum clinical actions observed after the drug within 2 - 3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Indications for use drugs: rheumatoid joint inflammation with severe course. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. Side effects and complications in the use of drugs: moderate signs of AR (skin rash, itching, hives, etc.), disruption of gastrointestinal tract Out the Door abdominal show-case flatulence). Method of production of drugs: Table., Coated tablets, 250 mg. Contraindications to the use of show-case hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Dosing and Administration of drugs: put in / m (in the buttocks), information about dosage of gold has empirical character; doses recommended, is not standard and should be chosen individually according to the pharmacokinetics of drugs auroterapiya gold starts with a test phase (definition of tolerance , dose selection, ranging from small concentrations), followed by transition to show-case phase of saturation, which is then extended using a maintenance dose that provides a stable level of gold in tissues; adults - first appointed two injections a week - from 1 through 3 - ve adults injected injection of 10 mg, from 4 th milligram 6 th injection - 20 mg and 7 th or injections administered 2 times a week to 50 mg, or 1 per week maximum 100 mg, this dose should be here to achieve a clinical effect, but not exceed the total dose of 1600 mg (maximum 2000 mg) if, after achieving this total dose was no clinical effect, treatment should be discontinued in the event of a clinical effect dose monthly maintenance treatment is 100 mg per injection or 50 mg 1 every 2 weeks, this treatment can continue months and years, depending on the activity of the process, appropriately increasing or decreasing the dose, but not exceed the maximum specified show-case . per day (morning and evening), then switching to a tab.